Metropolitan Life Insurance Company (MetLife)’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,123
| Closed | -$91.4K | – | 2032 |
|
|
2024
Q1 | $91.4K | Sell |
4,123
-232
| -5% | -$5.14K | ﹤0.01% | 1096 |
|
|
2023
Q4 | $120K | Hold |
4,355
| – | – | 0.01% | 985 |
|
|
2023
Q3 | $97.2K | Buy |
4,355
+283
| +7% | +$6.32K | 0.01% | 1033 |
|
|
2023
Q2 | $104K | Buy |
+4,072
| New | +$104K | 0.01% | 1001 |
|
|
2023
Q1 | – | Sell |
-4,527
| Closed | -$107K | – | 2469 |
|
|
2022
Q4 | $107K | Hold |
4,527
| – | – | ﹤0.01% | 1013 |
|
|
2022
Q3 | $75.1K | Hold |
4,527
| – | – | ﹤0.01% | 1189 |
|
|
2022
Q2 | $90.1K | Hold |
4,527
| – | – | ﹤0.01% | 1113 |
|
|
2022
Q1 | $125K | Sell |
4,527
-13,393
| -75% | -$369K | ﹤0.01% | 1065 |
|
|
2021
Q4 | $738K | Hold |
17,920
| – | – | 0.01% | 1166 |
|
|
2021
Q3 | $832K | Buy |
+17,920
| New | +$832K | 0.01% | 1102 |
|
|
2021
Q2 | – | Sell |
-18,079
| Closed | -$972K | – | 2887 |
|
|
2021
Q1 | $972K | Buy |
18,079
+1,281
| +8% | +$68.9K | 0.01% | 942 |
|
|
2020
Q4 | $822K | Buy |
16,798
+231
| +1% | +$11.3K | 0.01% | 1021 |
|
|
2020
Q3 | $538K | Buy |
16,567
+979
| +6% | +$31.8K | 0.01% | 1166 |
|
|
2020
Q2 | $404K | Buy |
15,588
+72
| +0.5% | +$1.87K | 0.01% | 1368 |
|
|
2020
Q1 | $377K | Hold |
15,516
| – | – | 0.01% | 1220 |
|
|
2019
Q4 | $433K | Hold |
15,516
| – | – | 0.01% | 1418 |
|
|
2019
Q3 | $372K | Buy |
15,516
+4,972
| +47% | +$119K | 0.01% | 1472 |
|
|
2019
Q2 | $301K | Hold |
10,544
| – | – | 0.01% | 1617 |
|
|
2019
Q1 | $264K | Hold |
10,544
| – | – | ﹤0.01% | 1712 |
|
|
2018
Q4 | $133K | Hold |
10,544
| – | – | ﹤0.01% | 2095 |
|
|
2018
Q3 | $101K | Buy |
+10,544
| New | +$101K | ﹤0.01% | 2449 |
|